$SKYE
Skye Bioscience, Inc.

2022 Q4 Form 10-Q Financial Statement

#000151655122000040 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.540M $1.141M
YoY Change 14.26% -23.52%
% of Gross Profit
Research & Development $1.537M $1.782M
YoY Change 38.07% 443.65%
% of Gross Profit
Depreciation & Amortization $31.53K $28.81K
YoY Change 27.55% 286.19%
% of Gross Profit
Operating Expenses $3.078M $2.922M
YoY Change 25.03% 60.64%
Operating Profit -$2.922M
YoY Change 60.64%
Interest Expense -$150.5K $211.2K
YoY Change 197.06% 8.12%
% of Operating Profit
Other Income/Expense, Net -$456.5K -$205.0K
YoY Change 3490.84%
Pretax Income -$9.890M -$3.127M
YoY Change 293.66% 71.38%
Income Tax $1.600K $0.00
% Of Pretax Income
Net Earnings -$9.892M -$3.127M
YoY Change 293.65% 71.38%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 912.2M shares 495.9M shares
Diluted Shares Outstanding 495.9M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.245M $415.4K
YoY Change -86.15% -96.25%
Cash & Equivalents $1.249M $415.4K
Short-Term Investments
Other Short-Term Assets $412.0K $143.9K
YoY Change 624.49% -58.2%
Inventory
Prepaid Expenses $850.4K $708.5K
Receivables $0.00
Other Receivables
Total Short-Term Assets $8.944M $2.683M
YoY Change -6.95% -76.53%
LONG-TERM ASSETS
Property, Plant & Equipment $87.85K $86.16K
YoY Change 0.16% 7.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.309K $8.309K
YoY Change 0.0% 0.0%
Total Long-Term Assets $167.4K $185.5K
YoY Change -31.13% -26.75%
TOTAL ASSETS
Total Short-Term Assets $8.944M $2.683M
Total Long-Term Assets $167.4K $185.5K
Total Assets $9.111M $2.869M
YoY Change -7.55% -75.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.670M $2.068M
YoY Change 85.99% 548.24%
Accrued Expenses $752.3K $842.1K
YoY Change 25.01% 84.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.848M $2.455M
YoY Change -6.41%
Total Short-Term Liabilities $12.12M $6.146M
YoY Change 209.78% 309.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $8.230K
YoY Change -100.0% -91.82%
Total Long-Term Liabilities $0.00 $8.230K
YoY Change -100.0% -99.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.12M $6.146M
Total Long-Term Liabilities $0.00 $8.230K
Total Liabilities $12.12M $6.154M
YoY Change 203.67% 79.81%
SHAREHOLDERS EQUITY
Retained Earnings -$66.74M -$56.85M
YoY Change 41.23% 27.05%
Common Stock $63.73M $53.56M
YoY Change 19.97% 1.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.008M -$3.285M
YoY Change
Total Liabilities & Shareholders Equity $9.111M $2.869M
YoY Change -7.55% -75.45%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$9.892M -$3.127M
YoY Change 293.65% 71.38%
Depreciation, Depletion And Amortization $31.53K $28.81K
YoY Change 27.55% 286.19%
Cash From Operating Activities -$4.872M -$2.057M
YoY Change 147.43% 38.35%
INVESTING ACTIVITIES
Capital Expenditures -$357.6K -$366.1K
YoY Change 561.71% 1273.11%
Acquisitions
YoY Change
Other Investing Activities $5.309M
YoY Change
Cash From Investing Activities $5.667M -$366.1K
YoY Change -10585.77% 1273.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 34.17K -91.85K
YoY Change -140.81% -101.24%
NET CHANGE
Cash From Operating Activities -4.872M -2.057M
Cash From Investing Activities 5.667M -366.1K
Cash From Financing Activities 34.17K -91.85K
Net Change In Cash 829.2K -2.515M
YoY Change -139.36% -142.59%
FREE CASH FLOW
Cash From Operating Activities -$4.872M -$2.057M
Capital Expenditures -$357.6K -$366.1K
Free Cash Flow -$4.514M -$1.691M
YoY Change 135.74% 15.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001516551
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55136
dei Entity Registrant Name
EntityRegistrantName
Skye Bioscience, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0692882
dei Entity Address Address Line1
EntityAddressAddressLine1
11250 El Camino Real,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
410-0266
dei Security12g Title
Security12gTitle
Common Stock, par value $0.001
dei Trading Symbol
TradingSymbol
SKYE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
912195626 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415389 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8983007 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4574 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4571 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
708477 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
554217 usd
CY2022Q3 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
0 usd
CY2021Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
13432 usd
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
1388444 usd
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
143859 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
56870 usd
CY2022Q3 us-gaap Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
22542 usd
CY2021Q4 us-gaap Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
0 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
2683285 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
9612097 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86163 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87710 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
91064 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
146972 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8309 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8309 usd
CY2022Q3 us-gaap Assets
Assets
2868821 usd
CY2021Q4 us-gaap Assets
Assets
9855088 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2067766 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
897880 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
120216 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
2130 usd
CY2022Q3 skye Accrued Interest Related Parties Current
AccruedInterestRelatedPartiesCurrent
305734 usd
CY2021Q4 skye Accrued Interest Related Parties Current
AccruedInterestRelatedPartiesCurrent
174911 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
443983 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
344450 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
30615 usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2022Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
526818 usd
CY2021Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
375842 usd
CY2022Q3 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
102390 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
0 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
326 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
59732 usd
CY2022Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
450000 usd
CY2021Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
450000 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2005371 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1524905 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
92356 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
82372 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6145575 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3912222 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8227 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78700 usd
CY2022Q3 us-gaap Liabilities
Liabilities
6153802 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3990922 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
495925112 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
495925112 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
476108445 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
476108445 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
495925 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
476108 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53065217 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
52644221 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56846123 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47256163 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3284981 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5864166 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2868821 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9855088 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1781724 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
327731 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4474531 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1818059 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1140558 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1491378 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4554131 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3567985 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2922282 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1819109 usd
us-gaap Operating Expenses
OperatingExpenses
9028662 usd
us-gaap Operating Expenses
OperatingExpenses
5386044 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2922282 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1819109 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9028662 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5386044 usd
CY2022Q3 skye Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-6228 usd
CY2021Q3 skye Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-189649 usd
skye Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-59406 usd
skye Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
169349 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
211229 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
195358 usd
us-gaap Interest Expense
InterestExpense
615563 usd
us-gaap Interest Expense
InterestExpense
570322 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
117953 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-205001 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5709 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-556157 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-621718 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3127283 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1824818 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9584819 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6007762 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5141 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3127283 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3127283 usd
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3127283 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1824818 usd
us-gaap Net Income Loss
NetIncomeLoss
-9589960 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9589960 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9589960 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6009362 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
495925112 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
413489603 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
495891596 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
376547498 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
495925112 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
414461032 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
495891596 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
376547498 shares
us-gaap Net Income Loss
NetIncomeLoss
-9589960 usd
us-gaap Net Income Loss
NetIncomeLoss
-6009362 usd
us-gaap Depreciation
Depreciation
83466 usd
us-gaap Depreciation
Depreciation
9412 usd
us-gaap Share Based Compensation
ShareBasedCompensation
425846 usd
us-gaap Share Based Compensation
ShareBasedCompensation
747252 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
59406 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-169349 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
480466 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
439053 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
117953 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-121277 usd
skye Increase Decrease In Other Current Assets From Related Party
IncreaseDecreaseInOtherCurrentAssetsFromRelatedParty
22542 usd
skye Increase Decrease In Other Current Assets From Related Party
IncreaseDecreaseInOtherCurrentAssetsFromRelatedParty
0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
131088 usd
skye Increase Decrease In Prepaid Expenses Due From Related Parties
IncreaseDecreaseInPrepaidExpensesDueFromRelatedParties
-13432 usd
skye Increase Decrease In Prepaid Expenses Due From Related Parties
IncreaseDecreaseInPrepaidExpensesDueFromRelatedParties
18125 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
86989 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
8309 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
370136 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-72719 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
118086 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
2968 usd
us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
130823 usd
us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
86737 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
99533 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
201334 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-60489 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6442 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1381 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
201861 usd
skye Increase Decrease In Other Current Liabilities Related Party
IncreaseDecreaseInOtherCurrentLiabilitiesRelatedParty
102390 usd
skye Increase Decrease In Other Current Liabilities Related Party
IncreaseDecreaseInOtherCurrentLiabilitiesRelatedParty
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7872550 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4506032 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
436554 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15556 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36828 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-452110 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36828 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
851538 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4783 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
244922 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-242955 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13163078 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8567615 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8620218 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8987578 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2473976 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
419963 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11094194 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415389 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11089624 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4574 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4570 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
419963 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11094194 usd
us-gaap Interest Paid Net
InterestPaidNet
4275 usd
us-gaap Interest Paid Net
InterestPaidNet
44087 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5141 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
skye Asset Acquisition Costs Incurred But Not Yet Paid
AssetAcquisitionCostsIncurredButNotYetPaid
951890 usd
skye Asset Acquisition Costs Incurred But Not Yet Paid
AssetAcquisitionCostsIncurredButNotYetPaid
0 usd
skye Financing Of Insurance Premium
FinancingOfInsurancePremium
275537 usd
skye Financing Of Insurance Premium
FinancingOfInsurancePremium
0 usd
skye Release Of Share Liability To Additional Paid In Capital
ReleaseOfShareLiabilityToAdditionalPaidInCapital
13000 usd
skye Release Of Share Liability To Additional Paid In Capital
ReleaseOfShareLiabilityToAdditionalPaidInCapital
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10455 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
39607 usd
skye Establishment Of Right Of Use Asset
EstablishmentOfRightOfUseAsset
0 usd
skye Establishment Of Right Of Use Asset
EstablishmentOfRightOfUseAsset
170606 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
83722 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3419278 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-301822 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
144124 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5864166 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
150358 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3043399 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2973092 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
144364 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3127283 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3284981 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
450786 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
146580 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2160517 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2478649 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111699 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4783 usd
us-gaap Net Income Loss
NetIncomeLoss
-9589960 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9589960 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2024027 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2271104 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
485723 usd
CY2021Q3 skye Stock Issued During Period Value Common Stock And Warrants
StockIssuedDuringPeriodValueCommonStockAndWarrants
6062774 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1824818 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
8264782 usd
CY2022Q3 skye Working Capital Earnings Deficit
WorkingCapitalEarningsDeficit
-3462290 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56846123 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415389 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2922282 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1819109 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9028662 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5386044 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3127283 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3127283 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3127283 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1824818 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9589960 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6009362 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates and judgements as to the appropriate carrying values of equity instruments, derivative liabilities, debt with embedded features, estimates related to the Company's estimation of the percentage of completion under its research and development contracts and the valuation of stock based compensation awards, which are not readily apparent from other sources.</span></div>
CY2022Q3 skye Research And Development Licensed Technology Costs Capitalized To Date
ResearchAndDevelopmentLicensedTechnologyCostsCapitalizedToDate
0 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3127283 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1824818 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9589960 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6009362 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
495925112 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
413489603 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
495891596 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
376547498 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3127283 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1704980 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9589960 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6009362 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
495925112 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
414461032 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
495891596 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
376547498 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
2683285 usd
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
1388444 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415389 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4574 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
708477 usd
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
1388444 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
143859 usd
CY2022Q3 us-gaap Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
22542 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86163 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
91064 usd
CY2022Q3 skye Promissory Note Receivable
PromissoryNoteReceivable
0 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8309 usd
CY2022Q3 us-gaap Assets
Assets
2868821 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2067766 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
120216 usd
CY2022Q3 skye Accrued Interest Related Parties Current
AccruedInterestRelatedPartiesCurrent
305734 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
443983 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
30615 usd
CY2022Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
526818 usd
CY2022Q3 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
102390 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
92356 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6145575 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
326 usd
CY2022Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
450000 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2005371 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8227 usd
CY2022Q3 us-gaap Liabilities
Liabilities
6153802 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
495925 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53065217 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56846123 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3284981 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2868821 usd
CY2022Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.73037
CY2022Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.73037
CY2022Q3 skye Class Of Warrant Or Right Warrants Vested And Outstanding
ClassOfWarrantOrRightWarrantsVestedAndOutstanding
136187225 shares
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
59732 usd
skye Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-59406 usd
skye Reclassification Of Derivatives To Equity
ReclassificationOfDerivativesToEquity
0 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
326 usd
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
38567 usd
skye Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
169349 usd
skye Reclassification Of Derivatives To Equity
ReclassificationOfDerivativesToEquity
0 usd
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
207916 usd
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
445 usd
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
44086 usd
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
44086 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
130824 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
130824 usd
CY2022Q3 skye Insurance Premium Expense
InsurancePremiumExpense
1602 usd
CY2021Q3 skye Insurance Premium Expense
InsurancePremiumExpense
0 usd
skye Insurance Premium Expense
InsurancePremiumExpense
4273 usd
skye Insurance Premium Expense
InsurancePremiumExpense
0 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
165082 usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
150852 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
479133 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
437834 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
459 usd
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
420 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1333 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1219 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
211229 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
195358 usd
us-gaap Interest Expense
InterestExpense
615563 usd
us-gaap Interest Expense
InterestExpense
570322 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
150000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
35405000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.07
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y29D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
134750 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4350000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.04
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
321250 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1678750 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.08
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
37755000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y5M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14782500 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.08
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y9M21D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.04
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
144124 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
488973 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
425846 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
747252 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1217236 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y7M24D
CY2021Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P2Y
CY2021Q3 skye Lessee Operating Lease Abatement Term
LesseeOperatingLeaseAbatementTerm
P2M
CY2021Q3 skye Lessee Operating Lease Initial Monthly Rent
LesseeOperatingLeaseInitialMonthlyRent
8067 usd
CY2021Q3 skye Lessee Operating Lease Annual Rent Increase Percent
LesseeOperatingLeaseAnnualRentIncreasePercent
0.03
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
22675 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
7558 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
68026 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
7558 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y29D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
24686 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
83093 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
107779 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7196 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
100583 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
92356 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8227 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
100583 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001516551-22-000040-index-headers.html Edgar Link pending
0001516551-22-000040-index.html Edgar Link pending
0001516551-22-000040.txt Edgar Link pending
0001516551-22-000040-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
noticeofgrantofstockoption.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sharepurchaseagreementrela.htm Edgar Link pending
Show.js Edgar Link pending
skye-20220930.htm Edgar Link pending
skye-20220930.xsd Edgar Link pending
skye-20220930xex311.htm Edgar Link pending
skye-20220930xex312.htm Edgar Link pending
skye-20220930xex321.htm Edgar Link pending
skye-20220930xex322.htm Edgar Link pending
skye-20220930_cal.xml Edgar Link unprocessable
skye-20220930_def.xml Edgar Link unprocessable
skye-20220930_lab.xml Edgar Link unprocessable
skye-20220930_pre.xml Edgar Link unprocessable
skye-20220930_htm.xml Edgar Link completed